Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P100
Near historical high
vs 2Y Ago
13.5x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 133.27% |
| 2023 | 69.76% |
| 2022 | 9.86% |
| 2021 | 0.00% |